SEC Form 4 · accession 0001144204-15-059433
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter A Lankau
Director
Period of report
Oct 12, 2015
Accepted (ET)
Oct 14, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 12, 2015 | A | 1,500 | $0.00 | A | 1,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $40.52 | Oct 12, 2015 | A | 3,000 | A | Oct 12, 2016 | Oct 11, 2025 | Common Stock | 3,000 | 3,000 | D |
Explanation of responses
- F1Of the common stock granted to the Reporting Person, 750 shares vest on October 12, 2016 and the remaining 750 shares vest on October 12, 2017.
- F2Of the common stock granted to the Reporting Person, options to purchase 1,500 shares vest on October 12, 2016 and the remaining options to purchase 1,500 shares vest on October 12, 2017.